Rituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach.

Abstract

Giant cell myocarditis (GCM) is a very aggressive form of myocardial inflammation. While immunosuppressive therapy is usually able to keep under control the disease and prolong the average transplant-free survival in many patients, effective therapeutic strategies to prevent or treat the recurrence of GCM in transplanted organs are still to be defined. We… (More)
DOI: 10.1111/tri.12270

Topics

  • Presentations referencing similar topics